Publikationen von F. Holsboer
Alle Typen
Zeitschriftenartikel (878)
661.
Zeitschriftenartikel
46, S. 1710 - 1711 (1999)
Behavioral, neuroendocrine and cardiovascular response to flumazenil: No evidence for an altered benzodiazepine receptor sensitivity in panic disorder - Reply. Biological Psychiatry 662.
Zeitschriftenartikel
45, S. 274 - 277 (1999)
Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biological Psychiatry 663.
Zeitschriftenartikel
246, S. 292 - 298 (1999)
Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. Journal of Neurology 664.
Zeitschriftenartikel
53, S. 772 - 777 (1999)
Dysregulation of the hypothalamic-pituitary-adrenal axis is related to the clinical course of multiple sclerosis. Neurology 665.
Zeitschriftenartikel
127, S. 863 - 868 (1999)
Bidirectional effects of the neuroactive steroid tetrahydrodeoxycorticosterone on GABA-activated Cl- currents in cultured rat hypothalamic neurons. British Journal of Pharmacology 666.
Zeitschriftenartikel
156, S. 949 - 951 (1999)
Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. American Journal of Psychiatry 667.
Zeitschriftenartikel
840, S. 525 - 531 (1998)
Cytokine expression and molecular mechanisms of their autocrine/paracrine regulation of anterior pituitary function and growth. Annals New York Academy of Sciences 668.
Zeitschriftenartikel
66, S. 113 - 121 (1998)
Oxidativer Stress in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion. Fortschritte der Neurologie/Psychiatrie 669.
Zeitschriftenartikel
18, S. 3903 - 3918 (1998)
Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. Journal of Neuroscience 670.
Zeitschriftenartikel
361, S. 17 - 26 (1998)
Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats. European Journal of Pharmacology 671.
Zeitschriftenartikel
38, S. 25 - 31 (1998)
Effects of thyreotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteers. Neuropsychobiology 672.
Zeitschriftenartikel
8, S. 71 - 79 (1998)
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment. Depression 673.
Zeitschriftenartikel
19, S. 114 - 122 (1998)
Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology 674.
Zeitschriftenartikel
50, S. 1149 - 1152 (1998)
In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 675.
Zeitschriftenartikel
3, S. 12 - 22 (1998)
Wirkmechanismen der Antidepressiva. Jatros Neurologie - Psychiatrie und Psychotherapie 676.
Zeitschriftenartikel
28, S. 2075 - 2085 (1998)
The Th1 and Th2 cytokines IFN-y and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1. European Journal of Immunology 677.
Zeitschriftenartikel
141, S. 213 - 219 (1998)
The GABAA receptor antagonist picrotoxin attenuates most of the sleep changes induced by progesterone. Psychopharmacology 678.
Zeitschriftenartikel
69, S. 574 - 585 (1998)
Die Münchner Vulnerabilitätsstudie zu affektiven Erkrankungen: Überblick über die Ergebnisse der Index-Untersuchung. Nervenarzt 679.
Zeitschriftenartikel
32, S. 393 - 401 (1998)
The Munich Vulnerability Study on Affective Disorders.: Overview of the cross-sectional observations at index assessment. Journal of Psychiatric Research 680.
Zeitschriftenartikel
51, S. 45 - 53 (1998)
The premorbid psychometric profile is stable over time in subjects at high familial risk for affective disorders. Journal of Affective Disorders